The gastroenteropancreatic neuroendocrine cell system and its tumors: The WHO classification

Annals of the New York Academy of Sciences

Volumn 1014, Issue , 2004, Pages 13-27

  Klöppel, Günter ^a   Perren, Aurel ^b   Heitz, Philipp U ^b  

^a UNIVERSITY OF KIEL   (Germany)

^b NONE

Author keywords

Carcinoids; Classification; Diagnosis; Neuroendocrine tumors; Prognosis

Indexed keywords

CALCITONIN; GASTRIN; OXYNTOMODULIN; SEROTONIN;

APPENDIX TUMOR; BENIGN TUMOR; CANCER CLASSIFICATION; CANCER GRADING; CANCER INCIDENCE; CANCER INVASION; CANCER LOCALIZATION; CARCINOID; CARCINOMA; CECUM TUMOR; CELL DIFFERENTIATION; CHROMAFFIN CELL; COLON TUMOR; DISEASE CLASSIFICATION; DISEASE SEVERITY; DUODENUM TUMOR; ECTOPIC HORMONE PRODUCTION; GASTRIN CELL; GASTRINOMA; GASTROINTESTINAL TUMOR; GLUCAGONOMA; HISTOPATHOLOGY; HORMONE SYNTHESIS; HUMAN; ILEUM TUMOR; IMMUNOCYTOCHEMISTRY; INSULINOMA; JEJUNUM TUMOR; NEUROENDOCRINE CARCINOMA; NEUROENDOCRINE TUMOR; NEUROSECRETORY CELL; PANCREAS TUMOR; PARAGANGLIOMA; RECTUM TUMOR; REVIEW; SOMATOSTATINOMA; STOMACH CARCINOMA; STOMACH MUCOSA; STOMACH TUMOR; TUMOR VOLUME; VIPOMA; WORLD HEALTH ORGANIZATION;

EID: 2342666214     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1294.002     Document Type: Review

References (34)

1. OBERNDORFER, S. 1907. Karzinoide Tumoren des Dünndarms. Frankf. Z. Pathol. 1: 426-432.
2. CAPELLA, C., P.U. HEITZ, H. HÖFLER, et al. 1995. Revised classification of neuroendocrine tumours of the lung, pancreas and gut. Virchows Arch. 425: 547-560.
3. KLÖPPEL, G., P.U. HEITZ, C. CAPELLA, et al. 1996. Pathology and nomenclature of human gastrointestinal neuroendocrine (carcinoid) tumors and related lesions. World J. Surg. 20: 132-141.
4. HÖFLER, H., H. STIER, V. SCHUSDZIARRA, et al. 1997. Klassifikation der neuroendokrinen Tumoren des Gastrointestinaltrakts und des Pankreas und ihre therapeutische Relevanz. Chirurg 68: 107-115.
5. BORDI, C., C. AZZONI, T. D'ADDA, et al. 1997. Neuroendokrine Tumoren des Magens. Pathologe 18: 313-321.
6. BORDI, C., T. D'ADDA, C. AZZONI, et al. 1998. Gastrointestinal endocrine tumors: recent developments. Endocr. Pathol. 9: 99-115.
7. KLÖPPEL, G. & P.U. HEITZ. 1981. Die disseminierten (diffusen) endokrinen Zellen. In Spezielle pathologische Anatomie, Bd 14. W. Doerr & G. Seifert, Eds. :1079-1135. Springer. Berlin.
8. WILLIAMS, E.D. & M. SANDLER. 1963. The classification of carcinoid tumours. Lancet 1: 238-239.
9. KLÖPPEL, G., P.U. HEITZ, C. CAPELLA, et al. 1995. The spectrum and classification of gastric and duodenal neuroendocrine tumours. Curr. Diag. Pathol. 2: 10-14.
10. SOLCIA, E., G. KLÖPPEL, L.H. SOBIN, et al. 2000. Histological typing of endocrine tumours. 2nd Ed. WHO International Histological Classification of Tumours. Springer. Berlin.
11. KLÖPPEL, G. & A. CLEMENS. 1996. The biological relevance of gastric neuroendocrine tumors. Yale J. Biol. Med. 69: 69-74.
12. RINDI, G., O. LUINETTI, M. CORNAGGIA, et al. 1993. Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinicopathologic study. Gastroenterology 104: 994-1006.
13. GODWIN, J.D. 1975. Carcinoid tumors. An analysis of 2837 cases. Cancer 36: 560-569.
14. MODLIN, I.M. & A. SANDOR. 1997. An analysis of 8305 cases of carcinoid tumors. Cancer 79: 813-829.
15. EISSELE, R., M. ANLAUF, M.K.H. SCHÄFER, et al. 1999. Expression of vesicular monoamine transporters in endocrine hyperplasia and endocrine tumors of the oxyntic stomach. Digestion 60: 428-439.
16. RINDI, G., D. PAOLOTTI, R. FIOCCA, et al. 2000. Vesicular monoamine transporter 2 as a marker of gastric enterochromaffin-like cell tumors. Virchows Arch. 436: 217-223.
17. RAPPEL, S., A. ALTENDORF-HOFMANN & M. STOLTE. 1995. Prognosis of gastric carcinoid tumours. Digestion 56: 455-462.
18. FEURLE, G.E., M. ANLAUF, G. HAMSCHER, et al. 2002. Xenin-immunoreactive cells and extractable xenin in neuroendocrine tumors of duodenal origin. Gastroenterology 123: 1616-1626.
19. PIPELEERS-MARICHAL, M.A., G. SOMERS, G. WILLEMS, et al. 1990. Gastrinomas in the duodenums of patients with multiple endocrine neoplasia type 1 and the Zollinger-Ellison syndrome. N. Engl. J. Med. 322: 723-727.
20. PIPELEERS-MARICHAL, M.A., C. DONOW, P.U. HEITZ, et al. 1993. Pathologic aspects of gastrinomas in patients with Zollinger Ellison syndrome with and without multiple endocrine neoplasia type I. World J. Surg. 17: 481-488.
21. DONOW, C., M.A. PIPELEERS-MARICHAL, S. SCHRODER, et al. 1991. Surgical pathology of gastrinoma. Site, size, multicentricity, association with multiple endocrine neoplasia type 1, and malignancy. Cancer 68: 1329-1334.
22. WEBER, H.C., D.J. VENZON, J.T. LIN, et al. 1995. Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: a prospective long-term study. Gastroenterology 108: 1637-1649.
23. GRABOWSKI, P., J. SCHÖNFELDER, G. AHNERT-HILGER, et al. 2002. Expression of neuroendocrine markers: a signature of human undifferentiated carcinoma of the colon and rectum. Virchow's Arch. 441: 256-263.
24. KLÖPPEL, G., P.A. IN'T VELD, P. KOMMINOTH, et al. 1998. The endocrine pancreas. In Functional Endocrine Pathology, 2nd Ed. K. Kovacs & S.L. Asa, Eds. :415-487. Blackwell. Boston.
25. HEYMANN, M.F., M. JOUBERT, J. NEMETH, et al. 2000. Prognostic and immunohistochemical validation of the Capella classification of pancreatic neuroendocrine tumours: an analysis of 82 sporadic cases. Histopathology 36: 421-432.
26. LA ROSA, S., F. SESSA, C. CAPELLA, et al. 1996. Prognostic criteria in nonfunctioning pancreatic endocrine tumours. Virchows Arch. 429: 323-333.
27. ROTH, J., G. KLÖPPEL, O. D. MADSEN, et al. 1992. Distribution patterns of proinsulin and insulin in human insulinomas: an immunohistochemical analysis in 76 tumors. Virchows Arch. [B] Cell Pathol. 63: 51-61.
28. CREUTZFELDT, W., R. ARNOLD, C. CREUTZFELDT, et al. 1973. Biochemical and morphological investigations of 30 human insulinomas. Correlation between the tumour content of insulin and proinsulin-like components and the histological and ultrastructural appearance. Diabetologia 9: 217-231.
29. GOEBEL, S.U., C. HEPPNER, A.L. BURNS, et al. 2000. Genotype/phenotype correlation of multiple endocrine neoplasia type 1 gene mutations in sporadic gastrinomas. J. Clin. Endocrinol. Metab. 85: 116-123.
30. BARGHORN, A., P. KOMMINOTH, D. BACHMANN, et al. 2001. Deletion at 3p25.3-p23 is frequently encountered in endocrine pancreatic tumours and is associated with metastatic progression. J. Pathol. 194: 451-458.
31. SPEEL, E.J., A.F. SCHEIDWEILER, J. ZHAO, et al. 2001. Genetic evidence for early divergence of small functioning and nonfunctioning endocrine pancreatic tumors: gain of 9Q34 is an early event in insulinomas. Cancer Res. 61: 5186-5192.
32. D'ADDA, T., S. PIZZI, C. AZZONI, et al. 2002. Different patterns of 11q allelic losses in digestive endocrine tumors. Hum. Pathol. 33: 322-329.
33. TÖNNIES, H., M.R. TOLIAT, C. RAMEL, et al. 2001. Analysis of sporadic neuroendocrine tumours of the enteropancreatic system by comparative genomic hybridisation. Gut 48: 536-541.
34. KYTÖLÄ, S., A. HÖÖG, B. NORD, et al. 2001. Comparative genomic hybridization identifies loss of 18q22-qter as an early and specific event in tumorigenesis of midgut carcinoids. Am. J. Pathol. 158: 1803-1808.